| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Dr. Reddys Lab | Pharmaceuticals& Drugs | 1,277.8 |
10.75 (0.85%) |
Mid Cap | 32,644 | 50.3 | 16.93 | 25.2 | 2.8 | |
| Zydus Lifesciences | Pharmaceuticals& Drugs | 1,088.9 |
3.45 (0.32%) |
Mid Cap | 23,242 | 50.1 | 19.92 | 21.7 | 4 | |
| Lupin | Pharmaceuticals& Drugs | 2,268.1 |
19.4 (0.86%) |
Mid Cap | 22,708 | 116.6 | 14.55 | 19.3 | 4.6 | |
| Glenmark Pharma | Pharmaceuticals& Drugs | 2,165.5 |
-15.95 (-0.73%) |
Mid Cap | 13,322 | 48.3 | 9.67 | 45.2 | 5.9 | |
| Aurobindo Pharma | Pharmaceuticals& Drugs | 1,462.6 |
-1.05 (-0.07%) |
Mid Cap | 10,933 | 42 | 15.17 | 34.9 | 3.7 | |
| Mankind Pharma | Pharmaceuticals& Drugs | 2,336.9 |
-17.5 (-0.74%) |
Mid Cap | 9,498 | 49.4 | 18.61 | 47.7 | 5.9 | |
| Alkem Laboratories | Pharmaceuticals& Drugs | 5,251.3 |
-25.1 (-0.48%) |
Mid Cap | 8,813 | 182.8 | 23.18 | 28.9 | 4.5 | |
| Max Healthcare Inst | Hospital &HealthcareServices | 977.1 |
10.8 (1.12%) |
Mid Cap | 7,028 | 14.8 | 16.05 | 65.2 | 8.8 | |
| Ipca Laboratories | Pharmaceuticals& Drugs | 1,643.1 |
23.15 (1.43%) |
Mid Cap | 6,635 | 44.6 | 12.45 | 36.3 | 5.2 | |
| Abbott India | Pharmaceuticals& Drugs | 26,017.7 |
183.5 (0.71%) |
Mid Cap | 6,409 | 730.4 | 22.1 | 35.4 | 11.5 | |
| Laurus Labs | Pharmaceuticals& Drugs | 1,447 |
19.8 (1.39%) |
Mid Cap | 5,554 | 16.5 | 5.63 | 86.8 | 14.5 | |
| Narayana Hrudayalay | Hospital &HealthcareServices | 1,970.1 |
21.15 (1.09%) |
Mid Cap | 5,483 | 39.4 | 14.35 | 49.4 | 8.8 | |
| Ajanta Pharma | Pharmaceuticals& Drugs | 2,977.6 |
29.95 (1.02%) |
Mid Cap | 4,648 | 84.5 | 19.35 | 34.9 | 8.1 | |
| Lenskart Solutions | MedicalEquipment/Supplies/Accessories | 506.2 |
-6.75 (-1.32%) |
Mid Cap | 4,039 | 2.7 | 4.65 | 187.4 | 9.8 | |
| Glaxosmithkline Phar | Pharmaceuticals& Drugs | 2,166.3 |
-0.2 (-0.01%) |
Mid Cap | 3,749 | 61.2 | 23.42 | 35.4 | 16.2 | |
| Biocon | Pharmaceuticals& Drugs | 412.1 |
-3.65 (-0.88%) |
Mid Cap | 2,243 | 0.2 | 8.04 | 1,811.3 | 2.5 | |
| Anthem Biosciences | Pharmaceuticals& Drugs | 762 |
16.4 (2.2%) |
Mid Cap | 1,841 | 11.9 | 27.24 | 62.6 | 13.2 | |
| Fortis Healthcare | Hospital &HealthcareServices | 969.3 |
29.45 (3.13%) |
Mid Cap | 1,446 | 3.1 | 9.99 | 308 | 7.7 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: